These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 23000404

  • 1. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M, Thommes M.
    Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
    [Abstract] [Full Text] [Related]

  • 2. Spheronization process particle kinematics determined by discrete element simulations and particle image velocimentry measurements.
    Koester M, García RE, Thommes M.
    Int J Pharm; 2014 Dec 30; 477(1-2):81-7. PubMed ID: 25304094
    [Abstract] [Full Text] [Related]

  • 3. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 30; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

  • 4. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 5. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M, Kleinebudde P.
    AAPS PharmSciTech; 2007 Nov 09; 8(4):E95. PubMed ID: 18181555
    [Abstract] [Full Text] [Related]

  • 6. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H, Podczeck F, Newton JM.
    Int J Pharm; 2012 Sep 15; 434(1-2):175-82. PubMed ID: 22659150
    [Abstract] [Full Text] [Related]

  • 7. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA.
    Acta Pharm; 2013 Mar 15; 63(1):85-98. PubMed ID: 23482315
    [Abstract] [Full Text] [Related]

  • 8. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM, Heng PW.
    Chem Pharm Bull (Tokyo); 2001 Nov 15; 49(11):1383-7. PubMed ID: 11724226
    [Abstract] [Full Text] [Related]

  • 9. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
    Saripella KK, Loka NC, Mallipeddi R, Rane AM, Neau SH.
    AAPS PharmSciTech; 2016 Apr 15; 17(2):368-79. PubMed ID: 26169900
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F, Knight P.
    Pharm Dev Technol; 2006 Apr 15; 11(3):263-74. PubMed ID: 16895837
    [Abstract] [Full Text] [Related]

  • 11. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug 15; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 12. Real-time image-based investigation of spheronization and drying phenomena using different pellet formulations.
    Burggraeve A, Sandler N, Heinämäki J, Räikkönen H, Remon JP, Vervaet C, De Beer T, Yliruusi J.
    Eur J Pharm Sci; 2011 Dec 18; 44(5):635-42. PubMed ID: 22033152
    [Abstract] [Full Text] [Related]

  • 13. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar 18; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

  • 14. The influence of model drugs on the preparation of pellets by extrusion/spheronization: II. Spheronization parameters.
    Tomer G, Podczeck F, Newton JM.
    Int J Pharm; 2002 Jan 01; 231(1):107-19. PubMed ID: 11719019
    [Abstract] [Full Text] [Related]

  • 15. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization.
    Mallipeddi R, Saripella KK, Neau SH.
    Int J Pharm; 2010 Jan 29; 385(1-2):53-65. PubMed ID: 19853027
    [Abstract] [Full Text] [Related]

  • 16. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW, Koo OM.
    Pharm Res; 2001 Apr 29; 18(4):480-7. PubMed ID: 11451035
    [Abstract] [Full Text] [Related]

  • 17. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep 29; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 18. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM, Wartewig S, Füting M, Heilmann A, Neubert RH, Kleinebudde P.
    AAPS PharmSci; 2003 Nov 19; 5(4):E31. PubMed ID: 15198519
    [Abstract] [Full Text] [Related]

  • 19. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S, Baie SH, Hay YK, Bukhari NI.
    Pak J Pharm Sci; 2014 May 19; 27(3):425-38. PubMed ID: 24811797
    [Abstract] [Full Text] [Related]

  • 20. Influence of starting material particle size on pellet surface roughness.
    Sarkar S, Ang BH, Liew CV.
    AAPS PharmSciTech; 2014 Feb 19; 15(1):131-9. PubMed ID: 24198222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.